Zopiclone and Caspofungin acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zopiclone (eszopiclone) and Caspofungin acetate (caspofungin acetate). Common drug interactions include rash maculo-papular among females and eosinophilia among males.

The phase IV clinical study analyzes what interactions people have when they take Zopiclone and Caspofungin acetate. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,330 Zopiclone users. Check the latest studies of Zopiclone.

What is Caspofungin acetate?

Caspofungin acetate has active ingredients of caspofungin acetate. eHealthMe is studying from 1,724 Caspofungin acetate users. Check the latest studies of Caspofungin acetate.



On Jul, 20, 2026

26 people who take Zopiclone and Caspofungin acetate together, and have interactions are studied.

Zopiclone and Caspofungin acetate drug interactions.

What are the common drug interactions of Zopiclone and Caspofungin Acetate, by gender? *:

female:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Acute respiratory distress syndrome
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Blood alkaline phosphatase increased
  7. Bradycardia (abnormally slow heart action)
  8. Chest discomfort
  9. Hyperbilirubinaemia (excess of bilirubin in the blood)
  10. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)

male:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Toxic skin eruption (skin breakdown due to toxic substance)
  5. Blindness
  6. Hypoacusis (loss of hearing)
  7. Arthralgia (joint pain)
  8. Back pain
  9. Osteonecrosis (death of bone)
  10. Congestive cardiomyopathy (weakening of heart muscle)

What are the common drug interactions of Zopiclone and Caspofungin Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Osteonecrosis (death of bone)
  4. Congestive cardiomyopathy (weakening of heart muscle)
  5. Diastolic dysfunction
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Osteoporosis (bones weak and more likely to break)
  8. Systolic dysfunction (impaired ventricular contraction)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

n/a

40-49:

  1. Acute respiratory distress syndrome
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Toxic skin eruption (skin breakdown due to toxic substance)
  3. Bradycardia (abnormally slow heart action)
  4. Chest discomfort
  5. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  6. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  7. Respiratory rate increased (excess breathing rate/min)

60+:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Blindness
  4. Hypoacusis (loss of hearing)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 7 people, 26.92%
  2. Lung Disorder (lung disease): 7 people, 26.92%
  3. High Blood Pressure: 7 people, 26.92%
  4. Cough: 7 people, 26.92%
  5. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 7 people, 26.92%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Zopiclone and Caspofungin acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zopiclone and Caspofungin acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Caspofungin acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Caspofungin acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone and caspofungin acetate (the active ingredients of Zopiclone and Caspofungin acetate, respectively), and Zopiclone and Caspofungin acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: